The 19th Congress of the European Hematology Association being held June 12 – 15 in Milan, Italy, the largest international hematology conference outside the United States, helps participating physicians to implement new research findings into their daily practice, making a tangible difference for their patients.
- Anna Falanga, MD, Assistant Professor Hematology-Oncology Department, Ospedali Riuniti di Bergamo, Bergamo, Italy, highlights the three presentations held at the Education Session on Thrombosis;
- Richard Schlenk MD, Professor of Internal Medicine III, University of Ulm, Ulm, Germany, reviews a selection of presentations regarding Acute Lymphoblastic Leukemia or ALL, a malignant (clonal) disease of the bone marrow in which early lymphoid precursors proliferate and replace the normal hematopoietic cells of the marrow; and
- Andreas Hochhaus MD, Professor of Internal Medicine, Hematology and Oncology and interim Head of the Department of Hematology and Medical Oncology at the University Medical Center Jena in Germany, discusses the highlights of the EHA congress on Chronic Myelogenous Leukemia (CML), a cancer that starts inside bone marrow which causes an uncontrolled growth of immature cells that make a certain type of white blood cell called myeloid cells.
Copyright ? 2014 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.